Darwin Global Management, Ltd. Verona Pharma PLC Call Options Transaction History
Darwin Global Management, Ltd.
- $1.44 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VRNA
# of Institutions
284Shares Held
71.4MCall Options Held
922KPut Options Held
1.97M-
Perceptive Advisors LLC New York, NY6.56MShares$457 Million17.44% of portfolio
-
Janus Henderson Group PLC London, X05.52MShares$384 Million0.2% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.46MShares$241 Million13.82% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.89MShares$202 Million3.9% of portfolio
-
Rtw Investments, LP New York, NY2.85MShares$199 Million2.96% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $4.25B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...